Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 335

1.

Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.

Brouxhon S, Kyrkanides S, O'Banion MK, Johnson R, Pearce DA, Centola GM, Miller JN, McGrath KH, Erdle B, Scott G, Schneider S, VanBuskirk J, Pentland AP.

Cancer Res. 2007 Aug 15;67(16):7654-64.

2.

Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.

Brouxhon S, Konger RL, VanBuskirk J, Sheu TJ, Ryan J, Erdle B, Almudevar A, Breyer RM, Scott G, Pentland AP.

J Invest Dermatol. 2007 Feb;127(2):439-46. Epub 2006 Sep 14.

3.
4.

Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.

Sung YM, He G, Hwang DH, Fischer SM.

Oncogene. 2006 Sep 7;25(40):5507-16. Epub 2006 Apr 10.

PMID:
16607275
5.

Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.

Ansari KM, Sung YM, He G, Fischer SM.

Carcinogenesis. 2007 Oct;28(10):2063-8. Epub 2007 Feb 2.

6.

E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.

Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA.

Cancer Res. 2005 Mar 1;65(5):1783-91.

7.

Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes.

Fouquet S, Lugo-Martínez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, Pinçon-Raymond M, Thenet S.

J Biol Chem. 2004 Oct 8;279(41):43061-9. Epub 2004 Aug 2.

8.

A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis.

Navarro P, Gómez M, Pizarro A, Gamallo C, Quintanilla M, Cano A.

J Cell Biol. 1991 Oct;115(2):517-33.

9.

WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.

Lai FJ, Cheng CL, Chen ST, Wu CH, Hsu LJ, Lee JY, Chao SC, Sheen MC, Shen CL, Chang NS, Sheu HM.

Clin Cancer Res. 2005 Aug 15;11(16):5769-77.

10.

Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin.

Toyoshima M, Tanaka N, Aoki J, Tanaka Y, Murata K, Kyuuma M, Kobayashi H, Ishii N, Yaegashi N, Sugamura K.

Cancer Res. 2007 Jun 1;67(11):5162-71.

11.

Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma.

Takeuchi T, Liang SB, Matsuyoshi N, Zhou S, Miyachi Y, Sonobe H, Ohtsuki Y.

Lab Invest. 2002 Aug;82(8):1023-9.

PMID:
12177241
13.

Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.

Llorens A, Rodrigo I, López-Barcons L, Gonzalez-Garrigues M, Lozano E, Vinyals A, Quintanilla M, Cano A, Fabra A.

Lab Invest. 1998 Sep;78(9):1131-42.

PMID:
9759657
14.

Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas.

Krishna SM, Kattoor J, Balaram P.

Cancer Biomark. 2005;1(6):271-7.

PMID:
17192051
15.
17.

Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.

Spinella F, Rosanò L, Di Castro V, Natali PG, Bagnato A.

J Biol Chem. 2004 Nov 5;279(45):46700-5. Epub 2004 Sep 3.

18.

Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors.

Kabashima K, Nagamachi M, Honda T, Nishigori C, Miyachi Y, Tokura Y, Narumiya S.

Lab Invest. 2007 Jan;87(1):49-55. Epub 2006 Oct 30.

20.

Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors.

Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M.

Am J Dermatopathol. 2004 Oct;26(5):372-8.

PMID:
15365368
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk